Publication | Open Access
Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both
87
Citations
18
References
2016
Year
isrctn.com Identifier: ISRCTN12808747.
| Year | Citations | |
|---|---|---|
Page 1
Page 1